Secondary Logo

Journal Logo

November 2016 - Volume 31 - Issue 6
pp: 301-357

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRISMA-1)

Llaudó, Jordi; Anta, Lourdes; Ayani, Ignacio; More

International Clinical Psychopharmacology. 31(6):323-331, November 2016.

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Benatti, Beatrice; Camuri, Giulia; Dell’Osso, Bernardo; More

International Clinical Psychopharmacology. 31(6):347-352, November 2016.